Status:

NOT_YET_RECRUITING

Prediction of Hepatocellular Carcinoma Recurrence After Curative Treatment by Monitoring Circulating Tumor DNA

Lead Sponsor:

University Hospital, Rouen

Conditions:

Hepatocellular Carcinoma

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

The goal of the REMNANT study is to confirm the clinical value of detecting a new biomarker, ctDNA (circulating tumor DNA), in the follow-up of patients with operated liver cancer. In order to meet th...

Detailed Description

Hepatocellular carcinoma (HCC) is the most common primary liver cancer and develops in 80% of cases in the context of underlying cirrhosis1. Surgical resection, percutaneous destruction and liver tran...

Eligibility Criteria

Inclusion

  • Age ≥ 18 years
  • HCC diagnosed on consensus radiological criteria in cirrhotic patients (EASL-EORTC 2012): helical CT or MRI with triple arterial, portal and late acquisition. The diagnosis is based on the presence of hypervascularization at the early arterial time (wash-in) with wash-out (hypodensity or hypointensity compared to non-tumor liver parenchyma) at the portal phase or late phase compared to non-tumor parenchyma.
  • HCC diagnosed histologically in the absence of a diagnosis on imaging (see IC n°2 above)
  • Patient operated on for liver resection or radiofrequency destruction
  • Treatment decision validated by the digestive oncology PCR
  • Patient having read and understood the information letter and signed the non-opposition form
  • Patient follow-up at the Charles Nicolle University Hospital in Rouen

Exclusion

  • Other active cancer or hematological malignancy
  • Contra-indication to surgery
  • Patient not affiliated to the social security system
  • Pregnant woman or parturient or breastfeeding
  • Person under court protection, sub guardianship or curatorship

Key Trial Info

Start Date :

September 1 2022

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

September 1 2026

Estimated Enrollment :

150 Patients enrolled

Trial Details

Trial ID

NCT05375370

Start Date

September 1 2022

End Date

September 1 2026

Last Update

May 20 2022

Active Locations (0)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 0 (0 locations)

No Results Found

We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.